Tag: Drug Pricing

  • Pharma Probe

    The public comment window closed Monday in the U.S. Trade Representative’s Section 301 investigation into Germany’s pharmaceutical pricing, hardening battle lines in a novel trade fight that could put tariffs on one of the world’s most sensitive industries. WASHINGTON, Aug. 12, 2026 A first of its kind American trade investigation into how a close ally…

  • Berlin Drug Row

    Comments are due tonight in the USTR’s Section 301 investigation of German pharmaceutical pricing, a case that could put tariffs behind Washington’s demand that wealthy allies pay more for American medicines WASHINGTON, Aug. 10, 2026 The public comment period in one of the most closely watched trade investigations of the year closes tonight at 11:59…

  • Pharma Cliff

    Six days before 100 percent tariffs hit patented medicines, three of the world’s biggest drugmakers still have no onshoring deal, generic makers have a new 200 percent deadline of their own, and the US drug supply chain is bracing for the most expensive week in its history WASHINGTON, July 25, 2026 The most consequential tariff…